News headlines about Simulations Plus (NASDAQ:SLP) have been trending very positive this week, according to Alpha One Sentiment Analysis. The research firm, a division of Accern, identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real time. Alpha One ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Simulations Plus earned a media sentiment score of 0.58 on Alpha One’s scale. Alpha One also assigned news stories about the technology company an impact score of 97 out of 100, indicating that recent press coverage is extremely likely to have an effect on the stock’s share price in the near future.
Here are some of the news stories that may have effected AlphaOne’s rankings:
- Simulations Plus (SLP) Record Prelim. Q3 Revenues of $6.69M (streetinsider.com)
- Simulations Plus : Reports Record Preliminary Revenues for Third Quarter FY2017 (4-traders.com)
- Simulations Plus, Inc. (SLP) Receives Consensus Recommendation of “Strong Buy” from Brokerages (americanbankingnews.com)
- Simulations Plus Reports Record Preliminary Revenues for Third Quarter FY2017 (finance.yahoo.com)
Shares of Simulations Plus (NASDAQ:SLP) traded down 1.24% on Friday, hitting $11.95. The company’s stock had a trading volume of 30,036 shares. The stock’s 50 day moving average is $12.05 and its 200-day moving average is $10.63. The company has a market cap of $206.02 million, a price-to-earnings ratio of 39.05 and a beta of -0.71. Simulations Plus has a 52 week low of $6.74 and a 52 week high of $13.00.
Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Monday, April 10th. The technology company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.08 by $0.01. Simulations Plus had a return on equity of 22.99% and a net margin of 24.92%. The firm had revenue of $5.71 million for the quarter, compared to analysts’ expectations of $5.54 million. On average, equities research analysts anticipate that Simulations Plus will post $0.31 earnings per share for the current year.
Separately, Zacks Investment Research lowered Simulations Plus from a “hold” rating to a “sell” rating in a research note on Thursday, April 27th.
ILLEGAL ACTIVITY NOTICE: “Simulations Plus (SLP) Getting Very Favorable News Coverage, Report Finds” was published by WKRB News and is the sole property of of WKRB News. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.wkrb13.com/markets/2230169/simulations-plus-slp-getting-very-favorable-news-coverage-report-finds.html.
In other Simulations Plus news, President Thaddeus Henry Grasela, Jr. sold 37,031 shares of Simulations Plus stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $11.63, for a total transaction of $430,670.53. Following the completion of the sale, the president now owns 426,852 shares of the company’s stock, valued at approximately $4,964,288.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Chairman Walter S. Woltosz sold 24,596 shares of Simulations Plus stock in a transaction on Thursday, May 4th. The shares were sold at an average price of $12.52, for a total transaction of $307,941.92. Following the sale, the chairman now directly owns 5,837,940 shares of the company’s stock, valued at approximately $73,091,008.80. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 142,511 shares of company stock worth $1,692,827. Corporate insiders own 36.93% of the company’s stock.
About Simulations Plus
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2230169/simulations-plus-slp-getting-very-favorable-news-coverage-report-finds.html
Receive News & Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.